A Frederick-based hospital has developed an aggressive screening and treatment program for lung cancer and now, it’s beating national averages for early detection and treatment. Today, Frederick ...

A new targeted therapy is significantly improving lung cancer patient outcomes. The drug is called Osimertinib, or brand name ...

2 Based on the histology of the NSCLC (squamous vs non-squamous), different chemotherapy backbones are applied. Despite the ...

In the quest for more targeted lung cancer treatments, a researcher at the University of Missouri thinks the solution may lie in tiny bubble-shaped packages that cells use to talk to each other.

In this video, Charu Aggarwal, MD, MPH, the Leslye M. Heisler Professor for Lung Cancer Excellence at University of ...

In recent research, treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically ...

A positive outlook and supportive medical professionals are crucial in navigating a cancer diagnosis and treatment journey.

Cemiplimab plus chemotherapy was found to be consistently effective in treating non-small cell lung cancer (NSCLC) and held up in the EMPOWER-Lung 3 trial. Prior efficacy results for overall survival ...

About 80% of people who have lung cancer have non-small-cell lung cancer. NSCLC usually spreads more slowly than small-cell lung cancers. Both cancers affect the lungs and have similar symptoms, but ...

Dr. Ross Camidge hopes talking about his cancer can help to de-stigmatize terminal illness and demonstrate that a person with ...

Race and economic disparities significantly affect lung cancer treatment and outcomes with worse outcomes seen in Black and ...

A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting ...